OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Microbiology is 95. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Characteristics of SARS-CoV-2 and COVID-19	3411
SARS-CoV-2 variants, spike mutations and immune escape	2778
Gut microbiota in human metabolic health and disease	2366
Coronavirus biology and replication: implications for SARS-CoV-2	2143
Long COVID: major findings, mechanisms and recommendations	1639
Antibiotic resistance in the environment	1085
The gut microbiota–brain axis in behaviour and brain disorders	1043
Infectious disease in an era of global change	723
Gut microbial metabolites as multi-kingdom intermediates	665
Considerations for diagnostic COVID-19 tests	576
SARS-CoV-2 pathogenesis	528
Transmissibility and transmission of respiratory viruses	502
The biofilm life cycle: expanding the conceptual model of biofilm formation	471
The evolution of SARS-CoV-2	444
Tackling the emerging threat of antifungal resistance to human health	438
Tolerance and resistance of microbial biofilms	430
Life and death in the soil microbiome: how ecological processes influence biogeochemistry	397
An evolving view on biogeochemical cycling of iron	382
Molecular mechanisms of antibiotic resistance revisited	367
Prevotella diversity, niches and interactions with the human host	327
The human virome: assembly, composition and host interactions	321
Structural biology of SARS-CoV-2 and implications for therapeutic development	310
Horizontal gene transfer and adaptive evolution in bacteria	304
Pathogenesis of human cytomegalovirus in the immunocompromised host	296
Innovations to culturing the uncultured microbial majority	296

Electromicrobiology: the ecophysiology of phylogenetically diverse electroactive microorganisms	287
Interactions between bacterial and phage communities in natural environments	274
The role of vaccines in combatting antimicrobial resistance	272
Microbial volatile organic compounds in intra-kingdom and inter-kingdom interactions	271
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis	259
Soil microbiomes and one health	259
Bile acids and the gut microbiota: metabolic interactions and impacts on disease	257
Bacillus subtilis biofilm formation and social interactions	255
Climate change impacts on plant pathogens, food security and paths forward	254
SARS-CoV-2 variant biology: immune escape, transmission and fitness	252
Beyond horizontal gene transfer: the role of plasmids in bacterial evolution	247
Skeletal infections: microbial pathogenesis, immunity and clinical management	238
The biofilm matrix: multitasking in a shared space	236
Priority effects in microbiome assembly	234
The stringent response and physiological roles of (pp)pGpp in bacteria	230
Biology and evolution of bacterial toxin–antitoxin systems	223
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract	222
Bacterial motility: machinery and mechanisms	215
Nutritional immunity: the battle for nutrient metals at the host–pathogen interface	214
Microbial diversity in extreme environments	212
Microbiome-based therapeutics	207
Carbohydrate-active enzymes (CAZymes) in the gut microbiome	204
Mass spectrometry-based metabolomics in microbiome investigations	203
The structural basis of herpesvirus entry	199
Infections at the maternal–fetal interface: an overview of pathogenesis and defence	197
Anti-tuberculosis treatment strategies and drug development: challenges and priorities	195
Crop microbiome and sustainable agriculture	194
The microbiome-shaping roles of bacteriocins	193
The rumen microbiome: balancing food security and environmental impacts	189
Immune evasion and provocation by Mycobacterium tuberculosis	188
Reconstructing organisms in silico: genome-scale models and their emerging applications	184
Evasion of plant immunity by microbial pathogens	177
Epstein–Barr virus and multiple sclerosis	173
Treatment strategies for cryptococcal infection: challenges, advances and future outlook	172
Examining horizontal gene transfer in microbial communities	170
Staphylococcus aureus host interactions and adaptation	170
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies	169
Microbial evolution and transitions along the parasite–mutualist continuum	168
Human papillomaviruses: diversity, infection and host interactions	166
Proximate and ultimate causes of the bactericidal action of antibiotics	166
The dynamic lung microbiome in health and disease	161
Microbial production of advanced biofuels	156
Physical properties of the bacterial outer membrane	150
Antibiofilm activity of host defence peptides: complexity provides opportunities	148
Composition and functions of bacterial membrane vesicles	141
Salmonella Typhimurium and inflammation: a pathogen-centric affair	139
The WHO fungal priority pathogens list as a game-changer	135
When anaerobes encounter oxygen: mechanisms of oxygen toxicity, tolerance and defence	134
Trichoderma: a multipurpose, plant-beneficial microorganism for eco-sustainable agriculture	130
Ecology, evolution and spillover of coronaviruses from bats	128

Architecture of bacterial respiratory chains	125
Ecology and impacts of white-nose syndrome on bats	125
Learning from the past: development of safe and effective COVID-19 vaccines	125
Toxoplasma gondii infection and its implications within the central nervous system	122
Nanomaterials arising amid antibiotic resistance	120
The highly diverse antiphage defence systems of bacteria	120
The marine nitrogen cycle: new developments and global change	118
Microbially mediated metal corrosion	118
Gradients and consequences of heterogeneity in biofilms	116
The ecological roles of bacterial chemotaxis	113
The interplay between microbial communities and soil properties	109
The effects of the COVID-19 pandemic on community respiratory virus activity	103
Architecture of the dynamic fungal cell wall	101
Diversity and evolution of the animal virome	100
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity	99
Influenza lineage extinction during the COVID-19 pandemic?	99
The gut–liver axis and gut microbiota in health and liver disease	99
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota	98
Structural biology of CRISPR–Cas immunity and genome editing enzymes	98
Host specificity of the gut microbiome	98
Revisiting the rules of life for viruses of microorganisms	95
Microbiota succession throughout life from the cradle to the grave	95